Literature DB >> 23105191

Construction of chimeric immunogens: Bioactive fragment of human IL-1β or polytuftsin (PT) capable of eliciting immune responses to HIV peptides.

K Gokulan1, S Khare, D N Rao.   

Abstract

In this study, we have examined the effect of linking of bloactive fragment of human IL-1β (163-171) or polytuftsin (PT, a synthetic polymer of natural immunomodulator "tuftsin") with synthetic peptides of HIV on the induction of immune response to the synthetic peptides. A panel of synthetic peptides representing defined region of gp41, gp120 and gag were used as antigens. Immunomodulators linked peptides (i.e. peptide-IL-1β or peptide-PT) or peptide dimers were employed for immunization in Balb/c mice. Mice immunized with the peptide-immunomodulator develop effective T-cell proliferation,in vitro cytokine release and higher antibody production, but not with peptide dimers. We also found that peptide-immunomodulators induced high level of IgG2a antibody production. Furthermore, there was a positive correlation between the levels of cytokine (IL-2 & IFN-γ) and IgG isotype production. Thus it would appear that incorporation of IL-1β fragment or PT selectively enhances the Th1 type response to these peptides and may therefore be important for virus neutralization and clearance. However, the effect of IL-1β fragment was found to be more pronounced than polytuftsin. Such an approach may provide effective vaccination against other infectious diseases.

Entities:  

Keywords:  Human interleukin-1β; Th-cells; chimeric immunogens; cytokines; polytuftsin

Year:  1998        PMID: 23105191      PMCID: PMC3453564          DOI: 10.1007/BF02867872

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

1.  Complement-fixing IgG1 constitutes a new subclass of mouse IgG.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Nature       Date:  1979-10-11       Impact factor: 49.962

2.  Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody.

Authors:  R Hunter; M Olsen; S Buynitzky
Journal:  Vaccine       Date:  1991-04       Impact factor: 3.641

3.  Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors.

Authors:  K Takayama; M Olsen; P Datta; R L Hunter
Journal:  Vaccine       Date:  1991-04       Impact factor: 3.641

4.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

5.  Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells.

Authors:  J Schmitz; M Assenmacher; A Radbruch
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

6.  Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection.

Authors:  M L Kalish; I J Check; R L Hunter
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

7.  Binding and internalization of the 163-171 fragment of human IL-1 beta.

Authors:  D Boraschi; P Ghiara; G Scapigliati; L Villa; A Sette; A Tagliabue
Journal:  Cytokine       Date:  1992-05       Impact factor: 3.861

8.  Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using 'tuftsin' for production of reactive oxygen intermediates.

Authors:  S Khare; L K Bhutani; D N Rao
Journal:  Lepr Rev       Date:  1993-09       Impact factor: 0.537

9.  Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.

Authors:  R Surkis; S Rubinraut; S Dagan; E Tzehoval; M Fridkin; R Ben Yoseph; R Catane
Journal:  Int J Biochem       Date:  1990

10.  Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin 1.

Authors:  K V Rao; A R Nayak
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.